BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33365277)

  • 21. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting mortality in geriatric patients hospitalized with COVID-19.
    Bağ Soytaş R; Ünal D; Arman P; Suzan V; Emiroğlu Gedik T; Can G; Korkmazer B; Karaali R; Börekçi Ş; Kuşkucu MA; Yavuzer H; Suna Erdinçler D; Döventaş A
    Turk J Med Sci; 2021 Apr; 51(2):454-463. PubMed ID: 33315348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
    Peng Y; Meng K; He M; Zhu R; Guan H; Ke Z; Leng L; Wang X; Liu B; Hu C; Ji Q; Keerman M; Cheng L; Wu T; Huang K; Zeng Q
    J Am Heart Assoc; 2020 Oct; 9(19):e016796. PubMed ID: 32794415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study.
    Jiang Y; Abudurexiti S; An MM; Cao D; Wei J; Gong P
    Sci Rep; 2020 Dec; 10(1):22369. PubMed ID: 33353956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could we predict the prognosis of the COVID-19 disease?
    Tahtasakal CA; Oncul A; Sevgi DY; Celik E; Ocal M; Turkkan HM; Bayraktar B; Oba S; Dokmetas I
    J Med Virol; 2021 Apr; 93(4):2420-2430. PubMed ID: 33368389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    He X; Wang L; Wang H; Xie Y; Yu Y; Sun J; Yan J; Du Y; Shen Y; Zeng H
    Sci Rep; 2020 Nov; 10(1):20452. PubMed ID: 33235220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
    Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
    Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
    Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
    J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.
    Tang Y; Sun J; Pan H; Yao F; Yuan Y; Zeng M; Ye G; Yang G; Zheng B; Fan J; Pan Y; Zhao Z; Guo S; Liu Y; Liao F; Duan Y; Jiao X; Li Y
    Cytokine; 2021 Jul; 143():155523. PubMed ID: 33840589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
    Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.